Bibliografía del artículo
1. De Burgos-Lunar C, Jiménez-García R, Salinero-Fort MA, Gómez-Campelo P, Gil A, Abádenes-Herranz JC, et al. Trends in hypertension prevalence, awareness, treatment and control in adult type 2 diabetes Spanish population between 2003 and 2009. PLoS One 9:e86713, 2014.
2. Brotons C, Alemán JJ, Banegas JR, Fondón C, Lobos-Bejarano JM, Martín E, et al. Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018 Aten Primaria 50 (supl 1):4-28, 2018.
3. Meador M, Osheroff JA, Reisler B. Improving identification and diagnosis of hypertensive patients hiding in plain sight (HIPS) in health centers. Jt Comm J Qual Patient Saf 44:117-129, 2018.
4. García-Morales G, Reyes-Jiménez M. Inercia clínica en pacientes con diabetes mellitus tipo 2 en una unidad de medicina familiar de Acapulco Guerrero, México. Aten Fam 24:102-106, 2017.
5. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. What is clinical inertia? Ann Inter Med 135:825-834, 2001.
6. García Vallejo O, Lozano JV, Vegazo O, Jiménez Jiménez FJ, Llisterri Caro JL, Redón J. Control de la presión arterial en pacientes diabéticos en Atención Primaria. Estudio DIAPA. Med Clin (Barc) 120:529-534, 2003
7. Choo EH, Ihm SY, Lim S, Chang K, Seung KB. A simple screening for undiagnosed hypertension. Int J Cardiol 172: e465-467, 2014.
8. Hernández-Mijares A, Solá-Izquierdo E, Ballester-Mechó F, Marí-Herrero MT, Gilabert-Molés JV, Gimeno-Clemente N, et al. Obesity and overweight prevalences in rural and urban populations in East Spain and its association with undiagnosed hypertension and diabetes mellitus: a cross-sectional population-based survey. BMC Res Notes 2:151, 2009.
9. Wallace ML, Magnan EM, Thorpe CT, Schumacher JR, Smith MA, Johnson HM. Diagnosis and treatment of incident hypertension among patients with diabetes: a U.S. Multi-Disciplinary Group Practice Observational Study. J Gen Intern Med 30(6):768-776, 2015.
10. American Diabetes Association. American Standards of Medical Care in Diabetes 2013. Diabetes Care 36(Suppl 1):S11-66, 2013.
11. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 31(7):1281-1357, 2013.
12. López-Simarro F. Inercia terapéutica. Causas y soluciones. Hipertensión y Riesgo Vascular 29(1):28-33, 2012.
13. Gil-Guillén V, Orozco-Beltrán D, Peset-Pérez R, Alfonso JL, Redon, J, Pertusa-Martínez S, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: Quantification and associated factors blood pressure 19:3-10, 2010.
14. Menéndez E, Delgado E, Fernández-Vega F, Prieto MA, Bordiú E, Calle A, et al. Prevalence, diagnosis, treatment, and control of hypertension in Spain. Results of the Di@bet.es Study. Rev Esp Cardiol (Engl Ed) 69:572-578, 2016.
15. Belizan M, Alonso JP, Nejamis A, Caporale J, Copo MG, Sánchez M, et al. Barriers to hypertension and diabetes management in primary health care in Argentina: qualitative research based on a behavioral economics approach. Transl Behav Med pii: ibz040. doi: 10.1093/tbm/ibz040, 2019.
16. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation 112:1651-1662, 2005.
17. Robles Perez-Monteoliva NR. Guías de hipertensión: Muchas y mal avenidas. Med Clin (Barc) 143:115-116, 2014.
18. Le?niak W, Ba?a MM, P?aczkiewicz-Jankowska E, Topór-M?dry R, Jankowski M, Sieradzki J, Banasiak W; ARETAEUS2 Study Group. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study. Cardiol J 22:150-159, 2015.
19. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes 2014-2020. Diabetes Care 43(Suppl1):S14-S31, 2020.
20. Al-Noumani H, Wu JR, Barksdale D, Alkhasawneh E, Knafl G, Sherwood G. Relationship between medication adherence and health beliefs among patients with hypertension in Oman: Pilot study. Sultan Qaboos Univ Med J 17:329-333, 2017.
21. Adrián-Arrieta L, Casas-Fernández de Tejerina JM. Autopercepción de enfermedad en pacientes con enfermedades crónicas. Medicina de Familia SEMERGEN 44:335-341, 2018.
22. Thomas J 3rd, Iyer NN, Collins WB. Associations between perceived chronic care quality, perceived patient centeredness, and illness representations among persons with diabetes. J Healthc Qual 36:50-59, 2014.
23. Nuño-Solinís R, Alonso-Morán E, Arteagoitia Axpe JM, Ezkurra Loiola P, Orueta JF, Gaztambide S. Costes sanitarios de la población con diabetes mellitus tipo 2 en el País Vasco. Aten Primaria 63:543-550, 2016.
24. Mosca I, Kenny RA. Exploring differences in prevalence of diagnosed, measured and undiagnosed hypertension: the case of Ireland and the United States of America. Int J Public Health 59:759-767, 2014.
25. National Institute for Health and Clinical Excellence. Hypertension in adults: diagnosis and management. NICE Guideline, 2019.
26. Mirza AA, Elmorsy SA. Diagnosis and control of hypertension as indicators of the level of awareness among relatives of medical students in Saudi Arabia. High Blood Press Cardiovasc Prev 23:123-132, 2016.
27. Márquez-Contreras E, De la Figuera Von Wichmann M, Aguilera de la Fuente MT, Garrido Garcia J. Influencia de la medida correcta de la presión arterial en la toma de decisiones diagnosticas en la hipertensión arterial. Estudio MEDIDA. Med Clin 131:321-325, 2008.
28. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev (3):CD005182, 2010.
29. Kenerson JG. Hypertension in Haiti: the challenge of best possible practice. J Clin Hypertens 16(2):107-114, 2014.